Understanding Participation Habits Among Plaque Psoriasis Patients
NCT06338358 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-03-29
Summary
The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal.
The data collected from this study will help improve future outcomes for all plaque psoriasis as well as those in under-represented demographic groups.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-30
- Primary Completion
- 2026-04-30
- Completion
- 2027-04-30
Countries
- United States
Study Locations
More Related Trials
-
Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
NCT01736696 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis
NCT06972888 ·Status: COMPLETED ·Phase: PHASE2
-
MAP Study: Methotrexate and Adalimumab in Psoriasis
NCT03217734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis
NCT04999839 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00237887 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
NCT05223868 ·Status: COMPLETED ·Phase: PHASE2
-
Immunologic Response to Secukinumab in Plaque Psoriasis
NCT02592018 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT01483924 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)
NCT01936688 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
NCT01401452 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
NCT05701995 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
NCT04316585 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
NCT00688519 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
NCT01700985 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
NCT04908514 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
NCT02502188 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of LY3361237 in Participants With Psoriasis
NCT04975295 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Patient Confidence in Biologic Medications
NCT03168347 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
NCT00773734 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
NCT02425826 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
NCT06176508 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
Psorcast Mobile Study
NCT05621369 ·Status: RECRUITING